CFDB - Cystic Fibrosis DataBase

All subcategories » published RCT

Improved residual fat malabsorption and growth in children with cystic fibrosis treated with a novel oral structured lipid supplement: A randomized controlled trial.

primary studies  published RCT

Details
  • 2020
  • Stallings VA

Effects of low glycemic index/high-fat, high-calorie diet on glycemic control and lipid profiles of children and adolescence with cystic fibrosis: A randomized double-blind controlled clinical trial.

primary studies  published RCT

Details
  • 2020
  • Gorji Z

Effects of synbiotic supplementation on the pulmonary manifestations and anthropometric measurements in children with cystic fibrosis- a randomized clinical trial

primary studies  published RCT

Details
  • 2020
  • N Bilan, E Marefat, M Nouri-Vaskeh, L Nikniaz, Z Nikniaz

Efficacy and safety of ataluren in patients with nonsense-mutation cystic fibrosis not receiving chronic inhaled aminoglycosides: The international, randomized, double-blind, placebo-controlled Ataluren Confirmatory Trial in Cystic Fibrosis (ACT CF).

primary studies  published RCT

Details
  • 2020
  • Konstan MW

A randomised controlled trial of rosuvastatin for the prevention of aminoglycoside-induced kidney toxicity in children with cystic fibrosis.

primary studies  published RCT

Details
  • 2020
  • McWilliam SJ

Lumacaftor/Ivacaftor reduces pulmonary exacerbations in patients irrespective of initial changes in FEV1.

primary studies  published RCT

Details
  • 2019
  • McColley SA

Impact of hypertonic saline nebulisation combined with oscillatory positive expiratory pressure on sputum expectoration and related symptoms in cystic fibrosis: a randomised crossover trial.

primary studies  published RCT

Details
  • 2019
  • San Miguel-Pagola M

Exenatide corrects postprandial hyperglycaemia in young people with cystic fibrosis and impaired glucose tolerance: A randomized crossover trial.

primary studies  published RCT

Details
  • 2019
  • Geyer MC

Dornase alfa during lower respiratory tract infection post-lung transplantation: a randomized controlled trial.

primary studies  published RCT

Details
  • 2019
  • Tarrant BJ

Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial.

primary studies  published RCT

Details
  • 2019
  • Heijerman HGM